Videos

Atheer Kaddis, PharmD, senior vice president of Business Development and Sales at Diplomat, discusses services offered by Diplomat's Hospital Specialty Program.

Neil Friedman, COO at Bodimetrics, describes the key functions and features of the Bodimetrics Performance Monitor.

James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses why DEA audits of pharmacies may be increasing.

Neil Friedman, COO at Bodimetrics, describes some of the key capabilities of the Bodimetrics Performance Monitor.

Cheryl Allen, RPh, BSPharm, MBA, vice president of Industry Relations at Diplomat, discusses how relationships can be improved between manufacturers, pharmacy benefit managers, and pharmacies.

Ronna B. Hauser, PharmD, vice president of pharmacy affairs for the National Community Pharmacists Association (NCPA), discusses what pharmacists need to know about the memorandum of understanding regarding the interstate shipment of compounds.

Andi Lane Clark, PharmD, Director of Clinical Field Services at Rite Aid, discusses the nuances between a pharmacist's method of intervention versus the practices of other health providers.

Andi Lane Clark, PharmD, Director of Clinical Field Services at Rite Aid, forecasts several different innovative solutions that are poised to drive better medication adherence over the next 2-3 years.

Andi Lane Clark, PharmD, Director of Clinical Field Services at Rite Aid, discusses how provider status would allow pharmacists to optimize their time and better support medication adherence for patients.

This weekly video program highlights the latest in pharmacy news, product news, and more.

James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some of the DEA's requirements for handling controlled substances.

Andi Lane Clark, PharmD, Director of Clinical Field Services at Rite Aid, outlines several ways in which Rite Aid demonstrates its commitment to the pharmacist's role in direct patient care.

Andi Lane Clark, PharmD, Director of Clinical Field Services at Rite Aid, outlines some of the latest pharmacy services developed by Rite Aid.

Jay Greco, RPh, owner of Jersey Shore Pharmacy, discusses significant issues causing difficulties for specialty pharmacy.

Andi Lane Clark, PharmD, Director of Clinical Field Services at Rite Aid, forecasts the ways in which pharmacy may change over the next 2-3 years.

Ronna B. Hauser, PharmD, vice president of pharmacy affairs for the National Community Pharmacists Association (NCPA), gives some tips for pharmacists on how to keep a quality, compliant compounding practice.

Marc O'Connor, chief operating officer of Curant Health, discusses methods Curant uses to maintain adherence to specialty drug regimens.

Nick Gentile, Director of State Grassroots Advocacy and Political Action for ASHP, discusses how compounding laws vary from state to state.

Andi Lane Clark, PharmD, Director of Clinical Field Services at Rite Aid, outlines several successful patient counseling techniques with respect to improved medication adherence.

Andi Lane Clark, PharmD, Director of Clinical Field Services at Rite Aid, discusses how proper medication adherence habits allow patients to better manage their chronic conditions.

Nick Gentile, Director of State Grassroots Advocacy and Political Action for ASHP, discusses the current status of provider status movements on the state level.

National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses the growth of the annual NASP Specialty Pharmacy Conference, held from Sept. 29 through Oct. 1, 2015.

Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC, discusses the difficulties pharmacies face regarding clinical support for patients starting specialty therapies.

Nick Gentile, Director of State Grassroots Advocacy and Political Action for ASHP, discusses different legislative issues generating buzz on the state level, including biosimilars.

Joseph Morse, president and chief operating officer of Therigy, LLC, discusses significant challenges in over the next five years in specialty pharmacy.

Nick Gentile, Director of State Grassroots Advocacy and Political Action for ASHP, discusses the current status of provider status movements on the state level.

This weekly video program highlights the latest in pharmacy news, product news, and more.

CEO of Avella Specialty Pharmacy Rebecca M. Shanahan, Esq., discusses how accountable care organizations impact specialty pharmacy.

David Lassen, chief clinical officer at Prime Therapeutics, discusses the potential long term impact from biosimilars on the specialty drug landscape.